HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kai-Lin Xu Selected Research

3- (formylhydroxyamino)- 2- (3- phenyl- 1- propyl)butanoic acid (2,2- dimethyl- 1- methylcarbamoyl- 1- propyl)amide

12/2015[Effect of ADAM10 Inhibitor GI254023X on Proliferation and Apoptosis of Multiple Myeloma H929 Cells and Its Possible Mechanisms].
8/2015[Effect of ADAM10 Inhibitor GI254023X on Proliferation and Apoptosis of Acute T-Lymphoblastic Leukemia Jurkat Cells In Vitro and Its Possible Mechanisms].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kai-Lin Xu Research Topics

Disease

16Leukemia
10/2020 - 02/2010
13Graft vs Host Disease (Graft-Versus-Host Disease)
06/2021 - 02/2007
9Multiple Myeloma
08/2021 - 10/2013
8Infections
04/2020 - 03/2009
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2019 - 06/2003
4Neoplasms (Cancer)
09/2018 - 10/2013
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2016 - 12/2013
3Aplastic Anemia (Anemia, Hypoplastic)
12/2022 - 06/2017
3Body Weight (Weight, Body)
06/2022 - 02/2017
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
06/2022 - 08/2018
3Blast Crisis (Blast Phase)
06/2019 - 01/2014
3Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
10/2015 - 06/2011
2Inflammation (Inflammations)
06/2020 - 10/2015
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2019 - 11/2016
2Liver Diseases (Liver Disease)
08/2018 - 06/2018
2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
04/2018 - 02/2015
2Lymphoma (Lymphomas)
04/2018 - 02/2010
2Disease Progression
02/2018 - 01/2014
2Philadelphia Chromosome
12/2016 - 12/2014
1Hirsutism
12/2022
1Hyperplasia
12/2022
1Cytokine Release Syndrome
08/2021
1Anemia
10/2020
1Lung Injury
06/2020
1Hematologic Diseases (Blood Diseases)
04/2020
1Neutropenia
04/2020
1B-Cell Leukemia (Leukemia, B Cell)
10/2019
1Hematologic Neoplasms (Hematological Malignancy)
10/2019
1Chromosome Aberrations (Chromosome Abnormalities)
08/2019
1Cytopenia
08/2019
1Refractory Anemia
08/2019
1Viremia
06/2019
1Hemorrhagic Cystitis
06/2019
1Splenomegaly
10/2018
1B-Cell Lymphoma (Lymphoma, B Cell)
03/2018
1Acute Monocytic Leukemia (Acute Monoblastic Leukemia)
03/2018
1Primary Myelofibrosis (Myelosclerosis)
02/2018
1Thrombocytopenia (Thrombopenia)
01/2018

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
06/2019 - 12/2013
5Small Interfering RNA (siRNA)IBA
08/2017 - 06/2013
4Messenger RNA (mRNA)IBA
10/2017 - 06/2012
3Chimeric Antigen ReceptorsIBA
08/2021 - 10/2019
3Biomarkers (Surrogate Marker)IBA
08/2020 - 12/2012
3CytokinesIBA
12/2015 - 06/2003
3Inosine Triphosphate (ITP)IBA
10/2015 - 06/2011
3Monoclonal AntibodiesIBA
12/2013 - 08/2009
2Cyclosporine (Ciclosporin)FDA LinkGeneric
12/2022 - 08/2019
2Interleukin-6 (Interleukin 6)IBA
08/2021 - 12/2015
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
08/2021 - 10/2018
2IronIBA
10/2020 - 08/2019
2Pharmaceutical PreparationsIBA
04/2020 - 06/2019
2TYK2 Kinase (Tyrosine Kinase 2)IBA
09/2019 - 09/2018
2Cytokine Receptors (Cytokine Receptor)IBA
09/2019 - 09/2018
2CateninsIBA
06/2019 - 12/2014
2Janus Kinase 2IBA
03/2019 - 02/2018
2molibresibIBA
12/2016 - 10/2014
2Oncogene Proteins (Oncogene Protein)IBA
11/2016 - 02/2015
23- (formylhydroxyamino)- 2- (3- phenyl- 1- propyl)butanoic acid (2,2- dimethyl- 1- methylcarbamoyl- 1- propyl)amideIBA
12/2015 - 08/2015
2cadherin 5IBA
12/2014 - 06/2011
2Interleukin-22 (IL-22)IBA
12/2013 - 12/2012
2CoagulantsIBA
06/2012 - 03/2009
2AntigensIBA
06/2012 - 06/2003
1AndrogensIBA
12/2022
1CalciumIBA
06/2022
1Hemoglobins (Hemoglobin)IBA
06/2022
1keratinaseIBA
06/2022
1Ferritins (Ferritin)IBA
08/2021
1C-Reactive ProteinIBA
08/2021
1Versicans (Versican)IBA
08/2020
1erucylphosphocholineIBA
06/2020
1Anti-Bacterial Agents (Antibiotics)IBA
04/2020
1Asparaginase (Elspar)FDA Link
10/2019
1CationsIBA
08/2019
1eltrombopagFDA Link
08/2019
1Coloring Agents (Dyes)IBA
06/2019
1thymoglobulinFDA Link
06/2019
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
03/2019
1LY2409881IBA
08/2018
1scriptaidIBA
08/2018
1Hepatitis B Surface Antigens (HBsAg)FDA Link
08/2018
1Histone Deacetylase InhibitorsIBA
08/2018
1P-SelectinIBA
04/2018
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
04/2018
1Fumigant 93 (D-D)IBA
04/2018
1artenimol (dihydroartemisinin)IBA
03/2018
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
03/2018
1bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
03/2018
1AlbuminsIBA
02/2018
1Janus Kinase InhibitorsIBA
02/2018
1CreatinineIBA
02/2018
1Serum AlbuminIBA
02/2018
1Arsenic Trioxide (Trisenox)FDA Link
01/2018
1Alanine Transaminase (SGPT)IBA
01/2018

Therapy/Procedure

8Therapeutics
12/2022 - 10/2013
8Hematopoietic Stem Cell Transplantation
06/2021 - 02/2017
8Bone Marrow Transplantation (Transplantation, Bone Marrow)
12/2013 - 11/2007
2Immunotherapy
08/2021 - 10/2019
2Transplantation
02/2017 - 02/2008
1Length of Stay
04/2020
1Subcutaneous Injections
04/2018